Embla Medical hfOSSFF 92 EV-to-EBITDA is 11.39 as of Jul. 08, 2026, which is 43% below its 10-year median of 19.88. GuruFocus rates OSSFF with a GF Score™ of 92/100 and a GF Value™ of $5.32. The stock has 2 warning signs investors should review. Among 512 Medical Devices & Instruments companies, Embla Medical hf ranks better than 60.74% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Embla Medical hf's enterprise value is $2,211.2 Mil.
Embla Medical hf's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $194.2 Mil. Therefore, Embla Medical hf's EV-to-EBITDA for today is 11.39.
The historical rank and industry rank for Embla Medical hf's EV-to-EBITDA or its related term are showing as below:
OSSFF'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 11.15 Med: 19.88 Max: 40.74
Current: 11.68
During the past 13 years, the highest EV-to-EBITDA of Embla Medical hf was 40.74. The lowest was 11.15. And the median was 19.88.
OSSFF's EV-to-EBITDA is ranked better than 60.74% of 512
companies
in the Medical Devices & Instruments industry
Industry Median: 14.3
vs OSSFF: 11.68
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Embla Medical hf (OTCPK:OSSFF) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Embla Medical hf's PE Ratio (TTM) for today is calculated as:
Embla Medical hf's share price for today is $4.15.
Embla Medical hf's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.202.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Embla Medical hf's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Embla Medical hf's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Embla Medical hf EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Embla Medical hf's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Embla Medical hf's EV-to-EBITDA falls into.
Embla Medical hf's current Enterprise Value is $2,211.2 Mil.
Embla Medical hf's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $194.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Embla Medical hf (OSSFF) has a EV-to-EBITDA of 11.39 as of Jul. 08, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Embla Medical hf. This is 43% below median its historical median of 19.88. Over the past decade, Embla Medical hf's EV-to-EBITDA has ranged from 11.15 to 40.74. According to the industry distribution chart, Embla Medical hf ranks #201 out of 512 companies in the Medical Devices & Instruments industry, placing it in the top 39.3%.
Is Embla Medical hf's EV-to-EBITDA too high?
Embla Medical hf's current EV-to-EBITDA of 11.39 is 43% below median its 10-year median of 19.88. Over the past 10 years, this metric has ranged from a low of 11.15 to a high of 40.74. The Medical Devices & Instruments industry median EV-to-EBITDA is 14.30. Embla Medical hf's value of 11.39 is 20.3% below this industry median. Based on the distribution chart, Embla Medical hf ranks #201 out of 512 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Embla Medical hf has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does Embla Medical hf's EV-to-EBITDA compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Embla Medical hf ranks #201 out of 512 companies for EV-to-EBITDA. This puts Embla Medical hf in the upper half of its industry. The industry median EV-to-EBITDA is 14.30. Embla Medical hf's value of 11.39 is 20.3% below this benchmark. Historically, Embla Medical hf's own EV-to-EBITDA has ranged from 11.15 to 40.74 over the past decade. While the company's 10-year median is 19.88 vs. the industry median of 14.30, Embla Medical hf has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.30, based on 512 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Embla Medical hf's current EV-to-EBITDA of 11.39 is 20.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Embla Medical hf. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Embla Medical hf's current EV-to-EBITDA is 11.39, which is 43% below median its own 10-year median of 19.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Embla Medical hf stock overvalued right now?
Embla Medical hf (OSSFF) has a current EV-to-EBITDA of 11.39. The stock's GF Value™ is $5.32, compared to a current price of $4.15 — trading 22% below its estimated fair value. The current EV-to-EBITDA is 11.39, which is 43% below median its 10-year median of 19.88 and 20.3% below the Medical Devices & Instruments industry median of 14.30. Embla Medical hf's overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Embla Medical hf (OSSFF), the current EV-to-EBITDA is 11.39 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Embla Medical hf (OSSFF) Overvalued in 2026?
Based on GuruFocus' analysis, Embla Medical hf stock appears to be undervalued.
The current stock price of $4.15 is trading 22% below its estimated GF Value™ of $5.32.
Key valuation signals for OSSFF:
EV-to-EBITDA: 11.39 (43% below median its 10-year median of 19.88)
GF Value™: $5.32 vs. price of $4.15 (22% below fair value)
Industry Position: 20.3% below the Medical Devices & Instruments median (#201 of 512)
No single metric tells the full story. See the OSSFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Embla Medical hf operates as an orthopedic products company specializing in the design, development, manufacturing and sales of prosthetics and bracing & supports products. The company also provides patient care through a network of Orthotic and Prosthetic (O&P) facilities. It sells its products in multiple countries, with Europe and North America representing its principal markets. The company operates within three business segments: Prosthetics & Neuro Orthotics, Bracing & Supports and Patient Care. The majority of the company's revenue is derived from the Prosthetics & Neuro Orthotics, which includes products designed for users with varying mobility needs, ranging from lower-activity applications to solutions intended for more active use.
92GF Score
Get the complete analysis for OSSFF
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSSFF has been successfully added to your 
